Come up with a name for your new list and we'll add to it:
Karuna Pharmaceuticals raised a round of funding on February 14, 2009. Investors include
Qualifying Therapeutic Discovery Project.
Karuna is a clinical-stage drug development company targeting muscarinic receptors for the treatment of psychosis and cognition across central nervous system (CNS) disorders, including schizophrenia a…